Company intelligence / Profile preview

Wuhan Optical Valley Zhongyuan Pharmaceutical

Wuhan, Hubei, China

Ownership: Private
Employees: ~224
Development stage: Other

Overview

Wuhan Optical Valley Zhongyuan Pharmaceutical is a subsidiary of Vcanbio Cell & Gene Engineering. It focuses on developing and manufacturing advanced cell therapies—primarily human umbilical cord-derived mesenchymal stem cell products—for immune-related and inflammatory diseases. Its lead asset, VUM02 injection, has reached Phase 2 clinical trials for steroid refractory graft versus host disease and received IND approval for several other indications including severe ulcerative colitis and liver/respiratory conditions. The company also has monoclonal antibody programs in early discovery.

Therapeutic areas: PulmonologyImmunologyGastroenterologyNeurology
Modalities: Mesenchymal stem cell therapyMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on Wuhan Optical Valley Zhongyuan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Optical Valley Zhongyuan Pharmaceutical.

Explore the full profile